Twist Bioscience and Biotia receive FDA EUA for hybridization-based NGS SARS-CoV-2 assay
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
ASTar enables rapid therapeutic response to sepsis directly from a positive blood culture
Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization
Strategic collaboration will introduce AI-enabled tools, optimized data-sharing, bring your own cloud (BYOC) support, and enhanced scalability
Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19
Deal enables a wider suite of pre-clinical testing services in oncology
AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19
Strategic agreement unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process
The new RNA extraction kits include the SPINeasy RNA Kit for Tissue, the SPINeasy RNA Kit for Bacteria, and the SPINeasy DNA/RNA/Protein All-In-One Kit